Immunocore Holdings plc American Depositary Shares (IMCR) — Analysis Summary
Immunocore Holdings plc American Depositary Shares (IMCR) has a market cap of $1.47B with year-over-year revenue growth of +29.0%. Net margin stands at -8.9%. The stock trades at a P/E ratio of -53.3.
Key Takeaways
- Revenue changed +29.0% year-over-year
- Net margin of -8.9%
- P/E ratio of -53.3
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, IMCR posted revenue growth of +29.0% and trades at a P/E of -53.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.